Watch the Full Interview with Paul Tudor Jones on the Election, Biden’s Tax Plan and Bitcoin (CNBC) Legendary hedge fund manager Paul Tudor Jones said...
Keep Reading →
October 22 - Hedge Funds, Insider Trading - Comments
Biotechnology is a very interesting industry to invest in, but also very complex. If you are looking for stocks that are most likely to see their value...
Keep Reading →
May 1 - Hedge Funds, News - Comments
Adaptimmune Therapeutics PLC – ADR (NASDAQ:ADAP): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors...
Keep Reading →
March 30 - Hedge Funds - Comments
Corvus Pharmaceuticals Inc (NASDAQ:CRVS): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors’ latest...
Keep Reading →
March 16 - Hedge Funds - Comments
Viewray Inc. (NASDAQ:VRAY): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors’ latest holdings and...
Keep Reading →
March 6 - Hedge Funds - Comments
Pieris Pharmaceuticals Inc. (NYSE:PIRS): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors’ latest...
Keep Reading →
February 22 - Hedge Funds - Comments
Nabriva Therapeutics PLC – ADR (NASDAQ:NBRV): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors’...
Keep Reading →
January 26 - Hedge Funds - Comments
Pieris Pharmaceuticals Inc. (NYSE:PIRS): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors’ latest...
Keep Reading →
January 26 - Hedge Funds - Comments
Alpine Immune Sciences Inc. (NASDAQ:ALPN): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors’ latest...
Keep Reading →
January 26 - Hedge Funds - Comments
Clementia Pharmaceuticals Inc (NASDAQ:CMTA): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors’ latest...
Keep Reading →
January 26 - Hedge Funds - Comments
Xtant Medical Holdings Inc. (OTCMKTS:XTNT): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors’ latest...
Keep Reading →
January 23 - Hedge Funds - Comments
Pieris Pharmaceuticals Inc. (NYSE:PIRS): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors’ latest...
Keep Reading →
January 8 - Hedge Funds - Comments
Scpharmaceuticals Inc (NASDAQ:SCPH): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors’ latest holdings...
Keep Reading →
December 4 - Hedge Funds - Comments
Arsanis Inc (NASDAQ:ASNS): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors’ latest holdings and filings...
Keep Reading →
December 1 - Hedge Funds - Comments
Loxo Oncology Inc. (NASDAQ:LOXO): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors’ latest holdings...
Keep Reading →
November 21 - Hedge Funds - Comments
Intellia Therapeutics Inc (NASDAQ:NTLA): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors’ latest...
Keep Reading →
November 9 - Hedge Funds - Comments
Viewray Inc (NASDAQ:VRAY): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors’ latest holdings and filings...
Keep Reading →
October 27 - Hedge Funds - Comments
Rhythm Pharmaceuticals Inc (NASDAQ:RYTM): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors’ latest...
Keep Reading →
October 23 - Hedge Funds - Comments
Roka Bioscience Inc. (NASDAQ:ROKA): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors’ latest holdings...
Keep Reading →
October 6 - Hedge Funds - Comments
Roka Bioscience Inc. (NASDAQ:ROKA): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors’ latest holdings...
Keep Reading →
October 3 - Hedge Funds - Comments
Roka Bioscience Inc. (ROKA): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors’ latest holdings and...
Keep Reading →
September 29 - Hedge Funds - Comments
Synlogic Inc. (NASDAQ:SYBX): Samuel Isaly’s OrbiMed Advisors filed an amended 13D. You can check out OrbiMed Advisors’ latest holdings and...
Keep Reading →
September 11 - Hedge Funds - Comments
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 12 – SEC Filing UNITED STATESSECURITIES AND EXCHANGE...
Keep Reading →
August 24 - Hedge Funds - Comments
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 11 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE...
Keep Reading →
August 23 - Hedge Funds - Comments
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 12 – SEC Filing UNITED STATESSECURITIES AND EXCHANGE...
Keep Reading →
August 16 - Hedge Funds - Comments
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 14 – SEC Filing UNITED STATESSECURITIES AND EXCHANGE...
Keep Reading →
August 11 - Hedge Funds - Comments
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 12 – SEC Filing UNITED STATESSECURITIES AND EXCHANGE...
Keep Reading →
August 9 - Hedge Funds - Comments
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 10 – SEC Filing UNITED STATESSECURITIES AND EXCHANGE...
Keep Reading →
August 3 - Hedge Funds - Comments
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 11 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE...
Keep Reading →
July 7 - Hedge Funds - Comments
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 14 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE...
Keep Reading →
June 22 - Hedge Funds - Comments
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 12 – SEC Filing UNITED STATESSECURITIES AND EXCHANGE...
Keep Reading →
May 8 - Hedge Funds - Comments
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 15 – SEC Filing UNITED STATES SECURITIES AND EXCHANGE...
Keep Reading →
April 28 - Hedge Funds - Comments
You can access the original SEC filing by clicking here. Ownership Summary Table Page 1 of 12 – SEC Filing UNITED STATESSECURITIES AND EXCHANGE...
Keep Reading →
March 22 - Hedge Funds - Comments
A freshly-amended 13D filing with the US SEC showed that Sam Isaly’s OrbiMed Advisors has sold some of its shares of Affimed N.V. (NASDAQ:AFMD), hence...
Keep Reading →
September 27 - Hedge Funds, News - Comments
Sam Isaly’s OrbiMed Advisors recently filed a Form 13D with the Securities and Exchange Commission in which reported the acquisition of 3.07 million...
Keep Reading →
August 14 - Hedge Funds, News - Comments
Samuel Isaly’s OrbiMed Advisors recently filed a 13D filing with the SEC in which it reported owning 2.18 million common shares of Loxo Oncology Inc...
Keep Reading →
August 8 - Hedge Funds, News - Comments
According to a recent 13G filing with the US Securities and Exchange Commission Sam Isaly’s Orbimed Advisors has increased its stake in Cynapsus Therapeutics...
Keep Reading →
July 12 - Hedge Funds, News - Comments
Samuel Isaly’s Orbimed Advisors recently filed a Form 13D with the Securities and Exchange Commission, in which it reported a new stake in Selecta Biosciences...
Keep Reading →
July 8 - Hedge Funds, News - Comments
Samuel Isaly just cannot get enough of Ascendis Pharma A/S (NASDAQ:ASND). According to an amended filing with the Securities and Exchange Commission,...
Keep Reading →
July 5 - Hedge Funds, News - Comments
Samuel Isaly‘s OrbiMed Advisors has stepped up its interest in Ascendis Pharma A/S (NASDAQ:ASND) as reported in a recently-amended filing with...
Keep Reading →
June 26 - Hedge Funds, News - Comments
Affimed NV (NASDAQ:AFMD) is the subject of a 13D filing from Samuel Isaly‘s OrbiMed Advisors, which shows that the investment firm has sold off...
Keep Reading →
March 31 - Hedge Funds, News - Comments
According to the Schulte, Roth & Zabel’s Activist Investing 2015 Annual Review, 344 companies were targeted by activist investors in 2014, as compared...
Keep Reading →
December 28 - Hedge Funds, News - Comments
You don’t necessarily need millions of dollars to invest like an activist investor such as Carl Icahn or Bill Ackman. Extensive research has concluded...
Keep Reading →
November 23 - Hedge Fund Analysis, Hedge Funds, News - Comments
It is easy to imagine that hedge funds would not reveal their equity positions if it were not for reporting requirements enforced by the Securities...
Keep Reading →
November 20 - Hedge Fund Analysis, Hedge Funds, News - Comments
It is commonly known that most hedge fund investors reveal their positions through 13F quarterly filings, but 13D filings tend to provide more insights...
Keep Reading →
November 2 - Hedge Fund Analysis, Hedge Funds, News - Comments
As U.S equities have plummeted on global-growth worries, confident hedge funds and other investors have started piling up more shares of companies that...
Keep Reading →
October 5 - Hedge Funds, Market Movers, News - Comments
Samuel Isaly’s OrbiMed Advisors is a healthcare fund with $15 billion worth of assets under management. The investment advisory firm has experience...
Keep Reading →
August 16 - Hedge Fund Analysis, Hedge Funds, News - Comments
Dennis Purcell’s Aisling Capital and Samuel Isaly’s OrbiMed Advisors have initiated new positions in Cynapsus Therapeutics Inc (NASDAQ:CYNA). In new...
Keep Reading →
July 7 - Hedge Funds, News - Comments
Glaukos Corp (NYSE:GKOS) is an $870 million developer of products for the treatment of glaucoma, which conducted its IPO last week with 6.90 million shares...
Keep Reading →
July 1 - Hedge Funds, News - Comments
Headquartered in Connecticut, Sarissa Capital Management was founded by Alexander J. Denner in 2012. Prior to this, Mr. Denner worked as a portfolio manager...
Keep Reading →
April 15 - Hedge Funds, News - Comments
